A Study Examining the Orbera365 Intragastric Balloon Safety and Effects on Weight Loss.

ABSTRACT:

Introduction

The Orbera365 is a new balloon that can stay in the stomach for up to 12 months. The aim of this study is to investigate the safety and effect of Orbera365.

Method

Prospective study on our initial experience with a consecutive group of patients who underwent the insertion of Orbera365 in the period between September 2019 and August 2020. The patients were followed up to assess, pain, nausea, and vomiting after procedure, weight loss, and the complication rate.

Results

A total of 97 patients underwent Orbera365 placement. Mean weight and BMI before the procedure were 93.8 ± 15.2 kg and 35.2 ± 4.4 kg/m², respectively, which dropped to 80.6 ± 13.1 kg and 29.8 ± 4.0 kg/m² by 8.2 months and were 82.4 ± 16.1 and 30.4 ± 4.6 at the last day

SUBMITTER: Jamal MH 

PROVIDER: S-EPMC8482955 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature